Beijing Chunlizhengda Medical Instruments Co., Ltd. (688236.SS)
CNY 13.46
(-1.1%)
CNY 13.46
(-1.1%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -1.25 Billion CNY | -31.14% |
| 2022 | -955.87 Million CNY | 44.91% |
| 2021 | -1.73 Billion CNY | -155.94% |
| 2020 | -677.99 Million CNY | -46.06% |
| 2019 | -464.17 Million CNY | -11.87% |
| 2018 | -414.91 Million CNY | -11.65% |
| 2017 | -371.61 Million CNY | -25.0% |
| 2016 | -297.28 Million CNY | -24.35% |
| 2015 | -239.06 Million CNY | -276.11% |
| 2014 | -63.56 Million CNY | 3.48% |
| 2013 | -65.85 Million CNY | -130287.65% |
| 2012 | -50.5 Thousand CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -1.21 Billion CNY | 2.78% |
| 2024 Q2 | -1.26 Billion CNY | -3.52% |
| 2024 Q3 | -1.15 Billion CNY | 8.45% |
| 2023 Q3 | -769.23 Million CNY | 9.97% |
| 2023 Q1 | -837.2 Million CNY | 12.42% |
| 2023 Q2 | -854.45 Million CNY | -2.06% |
| 2023 FY | -1.25 Billion CNY | -31.14% |
| 2023 Q4 | -1.25 Billion CNY | -62.96% |
| 2022 Q4 | -955.87 Million CNY | 10.42% |
| 2022 Q2 | -1.1 Billion CNY | -7.73% |
| 2022 FY | -955.87 Million CNY | 44.91% |
| 2022 Q1 | -1.02 Billion CNY | 40.88% |
| 2022 Q3 | -1.06 Billion CNY | 3.44% |
| 2021 Q1 | 689.97 Million CNY | 200.25% |
| 2021 FY | -1.73 Billion CNY | -155.94% |
| 2021 Q4 | -1.73 Billion CNY | 0.0% |
| 2021 Q2 | -597.17 Million CNY | -186.55% |
| 2020 Q4 | -688.26 Million CNY | 0.2% |
| 2020 FY | -677.99 Million CNY | -46.06% |
| 2020 Q2 | -458.25 Million CNY | -197.94% |
| 2020 Q3 | -689.62 Million CNY | -50.49% |
| 2020 Q1 | 467.9 Million CNY | 200.8% |
| 2019 Q3 | -464.43 Million CNY | -16.35% |
| 2019 Q1 | -399.16 Million CNY | 3.79% |
| 2019 Q2 | -399.16 Million CNY | 0.0% |
| 2019 FY | -464.17 Million CNY | -11.87% |
| 2019 Q4 | -464.17 Million CNY | 0.06% |
| 2018 Q4 | -414.91 Million CNY | 0.0% |
| 2018 Q2 | -389.01 Million CNY | 0.0% |
| 2018 Q1 | -389.01 Million CNY | -4.68% |
| 2018 Q3 | -414.91 Million CNY | -6.66% |
| 2018 FY | -414.91 Million CNY | -11.65% |
| 2017 Q1 | -307.76 Million CNY | -3.52% |
| 2017 Q4 | -371.61 Million CNY | 0.0% |
| 2017 FY | -371.61 Million CNY | -25.0% |
| 2017 Q3 | -371.61 Million CNY | -20.75% |
| 2017 Q2 | -307.76 Million CNY | 0.0% |
| 2016 FY | -297.28 Million CNY | -24.35% |
| 2016 Q2 | -233.41 Million CNY | 0.0% |
| 2016 Q1 | -233.41 Million CNY | 2.36% |
| 2016 Q3 | -297.28 Million CNY | -27.36% |
| 2016 Q4 | -297.28 Million CNY | 0.0% |
| 2015 Q4 | -239.06 Million CNY | 0.0% |
| 2015 Q2 | -222.31 Million CNY | -96163.11% |
| 2015 Q3 | -239.06 Million CNY | -7.54% |
| 2015 FY | -239.06 Million CNY | -276.11% |
| 2015 Q1 | -230.94 Thousand CNY | 99.64% |
| 2014 FY | -63.56 Million CNY | 3.48% |
| 2014 Q1 | 65.85 Million CNY | 34847.66% |
| 2014 Q4 | -63.56 Million CNY | 0.0% |
| 2013 FY | -65.85 Million CNY | -130287.65% |
| 2013 Q4 | -189.52 Thousand CNY | 0.0% |
| 2012 FY | -50.5 Thousand CNY | 0.0% |